Sources | Names Used |
---|---|
GDSC1000 | KIN001-260 |
PharmacoGx | KIN001-260 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MID1 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.007 |
mRNA | GATA2 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |
mRNA | STRIP1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |
mRNA | DIRC2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | CMA1 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.008 |
mRNA | TMCC3 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.008 |
mRNA | PIK3R5 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | CD2BP2 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.008 |
mRNA | PHF11 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.008 |
mRNA | SLCO4C1 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.008 |